Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma.

MLA

Yang Zhao, et al. “Radiofrequency Ablation Plays Double Role in Immunosuppression and Activation of PBMCs in Recurrent Hepatocellular Carcinoma.” Frontiers in Immunology, Feb. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1339213.

APA

Yang Zhao, Tongwang Yang, Yabo Ouyang, Wei Rao, Kai Liu, Jiasheng Zheng, Fudong Lv, Ying Shi, Feng Wang, Dongjie Liu, Luxin Qiao, Zhenying Xia, Yushi Zhang, Dexi Chen, & Wenjing Wang. (2024). Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Frontiers in Immunology, 1–13. https://doi.org/10.3389/fimmu.2024.1339213

Chicago

Yang Zhao, Tongwang Yang, Yabo Ouyang, Wei Rao, Kai Liu, Jiasheng Zheng, Fudong Lv, et al. 2024. “Radiofrequency Ablation Plays Double Role in Immunosuppression and Activation of PBMCs in Recurrent Hepatocellular Carcinoma.” Frontiers in Immunology, February, 1–13. doi:10.3389/fimmu.2024.1339213.